Methylphenidate for adults with ADHD
Part of Mental health clinical trials.
This trial tests whether methylphenidate (a stimulant medicine) helps adults with attention-deficit/hyperactivity disorder (ADHD). It is checking safety and effectiveness for people who can take the immediate-release form of the medicine.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are White Brazilian and of European descent
- A doctor has diagnosed you with ADHD based on DSM-IV criteria
- You are able to take immediate-release methylphenidate (IR-MPH) right away
- You do NOT have a medical reason you can’t safely take IR-MPH
- You are NOT currently taking stimulant medicines
- You do NOT have certain brain/nerve conditions or a history of psychosis
- Your IQ score is 70 or higher
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study compares two ADHD medicines—lisdexamfetamine and methylphenidate—in children who have ADHD and type 1 diabetes. It’s designed to see which option works better and is safe/effective for managing ADHD without causing major problems for diabetes care.
This Phase 3 study tests how methylphenidate affects brain signals and attention in adults with ADHD, and in adults with mood-related attention problems. It also includes healthy volunteers to compare brain responses during brain scanning.
This study looks at how methylphenidate (Ritalin) is processed in the body in adults with ADHD, and whether this differs between people with obesity and those without. It aims to help doctors give the right dose to each person.
This study tests a medication called Foquest to see if it helps older adults with ADHD. It aims to improve attention and reduce hyperactivity or impulsivity in people aged 65 and above.
This study tests if the medication methylphenidate (commonly used for ADHD) can help manage attention and behavior problems in people with KBG syndrome. Each person acts as their own test case to see if the drug works for them.
This study looks at whether the medication methylphenidate (often used for ADHD) can help people who have both ADHD and an addiction. It aims to see if the medicine is safe and works well for people with both conditions.
Hear when a new Attention Deficit Disorder With Hyperactivity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.